UNVEILING NOVEL BIOMARKERS FOR EARLY DISEASE DETECTION

Early diagnosis of ailments is vital for improving patient outcomes and reducing the burden of chronic conditions. Traditionally, disease screening has relied on symptomatic observations and destructive diagnostic procedures. However, these approaches often fail to detect diseases in their preclinical stages, when intervention is highly effective.